Trial Profile
Iloprost for Bridging to Heart Transplantation in Patients with Pulmonary Hypertension and Left Heart Failure
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions; Therapeutic Use
- Acronyms BRIDGE
- 19 Dec 2019 Planned primary completion date changed from 1 Sep 2016 to 17 Mar 2015.
- 25 Jun 2015 Status changed from recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov record.
- 11 Jul 2014 New trial record